Malin Corporation | MLC - Ordinary Share Capital

Stock Price
7.85
Daily Change
-0.15 -1.88%
Monthly
1.95%
Yearly
-23.04%
Q1 Forecast
7.76

Malin Corporation reported EUR200K in Ordinary Share Capital for its fiscal semester ending in December of 2024.





Ordinary Share Capital Change Date
Alaunos Therapeutics USD 2.21M 2.2M Sep/2025
ALKERMES USD 165.1M 49K Sep/2025
Dianthus Therapeutics USD 42.85M 42.82M Sep/2025
Eurofins Scientific SE EUR 177.9M 0 Dec/2025
Ionis Pharmaceuticals USD 161.14M 160.98M Sep/2025
IQVIA Holdings USD 170.3M 300K Sep/2025
Lonza CHF 72M 0 Dec/2024
Malin Corporation EUR 200K 0 Dec/2024
Moderna USD 391M 2M Sep/2025
Organon & Co USD 259.98M 18K Sep/2025
Revvity USD 116.07M 258K Sep/2025
Tectonic Therapeutic USD 14.86M 111.83K Dec/2024
Viatris USD 1.16B 6.55M Sep/2025
Xeris Pharmaceuticals USD 165.53M 165.51M Sep/2025